Simple Summary Breast cancer is one of the most common malignant tumors in women. Its
incidence rate accounts for 7–10% of all kinds of malignant tumors in the whole body …

Breast cancer, as a heterogeneous disease, includes a wide range of pathological and
clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and …

The second leading cause of cancer death in women worldwide is breast cancer (BC), and
despite significant advances in BC therapies, a significant proportion of patients develop …

Breast cancer (BC) is one of the most widespread malignancies in women worldwide. Breast
cancer is mainly classified into a few key molecular subtypes in accordance with hormone …

Breast cancer is a common disease in women in worldwide. Although conventional
approaches such as surgery, radiotherapy chemotherapy, and endocrine therapy contribute …

Triple-negative breast cancer (TNBC) refers to cancers that are low in expression of the
estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …

Immunotherapy is a major emerging treatment for breast cancer (BC). However, not all
breast cancer patients derive benefit from immunotherapy. Predictive biomarkers of …

Breast cancer is the most commonly diagnosed cancer among women. Therapeutic
treatments for breast cancer generally include surgery, chemotherapy, radiotherapy …

Breast cancer is the second leading cause of death for women worldwide. The
heterogeneity of this disease presents a big challenge in its therapeutic management …

Among the new cancer cases and resulting deaths among women worldwide, breast cancer
is the most significant threat to women's health. In recent years, immunotherapy was initially …